Literature DB >> 12925383

Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases.

Bethany R Hairston1, Mark D P Davis, Lawrence E Gibson, Lisa A Drage.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12925383     DOI: 10.1001/archderm.139.8.987

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  11 in total

1.  Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin.

Authors:  Jihane Abou Rahal; Rim S Ishak; Zaher K Otrock; Abdul-Ghani Kibbi; Ali T Taher
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

2.  Enhanced functional stability of plasminogen activator inhibitor-1 in patients with livedoid vasculopathy.

Authors:  Mehmet Agirbasli; Mesut Eren; Fatih Eren; Sheila B Murphy; Zehra A Serdar; Dilek Seckin; Tuba Zara; M Cem Mat; Cuyan Demirkesen; Douglas E Vaughan
Journal:  J Thromb Thrombolysis       Date:  2011-07       Impact factor: 2.300

Review 3.  [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction].

Authors:  T Goerge
Journal:  Hautarzt       Date:  2011-08       Impact factor: 0.751

4.  Lower extremity ulcers in systemic sclerosis: features and response to therapy.

Authors:  Victoria K Shanmugam; Patricia Price; Christopher E Attinger; Virginia D Steen
Journal:  Int J Rheumatol       Date:  2010-08-18

5.  Livedoid vasculopathy associated with combined prothrombin G20210A and factor V (Leiden) heterozygosity and MTHFR C677T homozygosity.

Authors:  Noha A Irani-Hakime; Farid Stephan; Raghid Kreidy; Isabelle Jureidini; Wassim Y Almawi
Journal:  J Thromb Thrombolysis       Date:  2008-03-23       Impact factor: 2.300

6.  [Livedoid vasculopathy with heterozygous factor V Leiden mutation and sticky platelet syndrome].

Authors:  V Lewerenz; T Burchardt; A Büchau; T Ruzicka; M Megahed
Journal:  Hautarzt       Date:  2004-04       Impact factor: 0.751

7.  A Phase II Multicenter Trial With Rivaroxaban in the Treatment of Livedoid Vasculopathy Assessing Pain on a Visual Analog Scale.

Authors:  Attyla Drabik; Carina Hillgruber; Tobias Goerge
Journal:  JMIR Res Protoc       Date:  2014-12-10

Review 8.  Livedoid vasculopathy: A multidisciplinary clinical approach to diagnosis and management.

Authors:  Asli Bilgic; Salih Ozcobanoglu; Burcin Cansu Bozca; Erkan Alpsoy
Journal:  Int J Womens Dermatol       Date:  2021-09-02

Review 9.  Comparative Efficacy of Rivaroxaban and Immunoglobulin Therapy in the Treatment of Livedoid Vasculopathy: A Systematic Review.

Authors:  Shivana Ramphall; Swarnima Rijal; Vishakh Prakash; Heba Ekladios; Jiya Mulayamkuzhiyil Saju; Naishal Mandal; Nang I Kham; Rabia Shahid; Shaili S Naik; Sathish Venugopal
Journal:  Cureus       Date:  2022-08-27

10.  Painless Livedoid Vasculopathy in a Patient with G20210A Prothrombin Gene Mutation.

Authors:  Aibek E Mirrakhimov; Erwin Velasquez Kho; Alaa Ali
Journal:  Case Rep Med       Date:  2012-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.